arrow
Return

Superficial parasternal intercostal plane block with ropivacaine versus placebo for opioid exposure after cardiac surgery (EPOCH CardioLink-10): a multicentre, double-blind, randomised trial

delete2026-05-28
delete0
delete
OA
AI
A
Ahmad Alli
C
C. David Mazer *
F
Fallon Dennis
H
Hwee Teoh
K
Kyle Chin
A
Adrian Quan
S
Syed M. Ali Hassan
M
Michael Szarek
J
John D. Tran
N
Nitish K Dhingra
J
Juan P. Ghiringhelli
F
Fábio de Vasconcelos Papa
Y
Youngseo Lee
M
Michael J. Ricci
R
Raj Verma
K
Kendra L. Derry
T
Thomas George
A
Aishwarya Krishnaraj
D
David A. Hess
O
Ori D. Rotstein
DOI:10.1016/j.lana.2026.101508delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Cardiac surgery performed through a midline chest incision (median sternotomy) is associated with substantial postoperative pain and opioid use, the latter of which remains the dominant modality of analgesia. Contemporary international guidelines prioritise opioid-sparing, multimodal strategies; however, robust randomised evidence to support specific opioid-sparing analgesic approaches in cardiac surgery is lacking.
Keywords:
Perioperative pain management
Cardiac surgery
Opioid consumption superficial parasternal intercostal plane block
SPIP block
Median sternotomy
Postoperative pain
Opioid-sparing analgesia
Ropivacaine
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

T
The Lancet Regional Health - Americas
IF:
0
Papers:
174
Citations:
0

Organization

No organization information available